For the years ended December 31, 2018 and 2017, the Company paid approximately $33,000 and $16,000, respectively, in consulting fees to a director of the Company. As of December 31, 2018, the Company owed $8 thousand to a director for consulting services.

During April 2016, the Company entered into a consulting agreement with Montel Media, Inc. (“Montel Media”), pursuant to which Montel Media provides consulting services for the promotion of the Company’s clinical trials and ongoing media and marketing strategies. Under the agreement, Montel Media received $15 thousand per month. During the first quarter of 2018, the Company terminated its agreement with Montel Media. Montel Media is owned by Montel Williams, who beneficially owns greater than 5% of the Company’s common stock. The Company paid Montel Media $45,000 and $0.2 million for the years ended December 31, 2018 and 2017, respectively, pursuant to the consulting agreement.

For the years ended December 31, 2018, a benefit of $0.3 million compared to an expense $0.4 million for the year ended December 31, 2017 was included in the change in fair value of derivative financial instruments as the fair value of stock-based compensation attributed to the options granted to a director for consulting services rendered with respect to the design and development of the PoNS device.

The Company’s Chief Medical Officer is a founding member of Clinvue LLC, a company that provides regulatory advisory services for the Company. The Company paid Clinvue LLC approximately $0.1 million for consulting services in each of the years ended December 31, 2018 and 2017.

The Company’s Chief Executive Officer, Chief Financial Officer/Chief Operating Officer, two directors and A&B, a greater than 5% owner of the Company’s outstanding shares, subscribed for units in the Company’s December 2017 Financing.

The following table summarizes their participation (subscription amount in thousands):

	Units Purchased		Subscription Amount
A&B (HK) Company Ltd.		204,081	$	2,000
Director 1		76,530		750
Director 2		51,019		500
CEO		25,510		250
CFO/COO		15,816		155
		372,956	$	3,655